Dashboard
Manage Tickers

ISEEIVERIC bio, Inc.

Nasdaq ivericbio.com


$ 39.95 $ 0.15 (0.38 %)    

Monday, 10-Jul-2023 16:01:14 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 433.04 $ 1.75 (0.41 %)
DIA $ 383.81 $ 1.49 (0.39 %)
SPY $ 510.06 $ 1.80 (0.35 %)
TLT $ 88.99 $ 0.74 (0.84 %)
GLD $ 216.18 $ -0.44 (-0.2 %)
$ 39.95
$ 39.87
$ 39.94 x 600
$ 39.97 x 600
$ 39.87 - $ 39.98
$ 9.39 - $ 39.99
10,999,110
na
5.48B
$ 1.63
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-10-2023 03-31-2023 10-Q
2 03-01-2023 12-31-2022 10-K
3 11-04-2022 09-30-2022 10-Q
4 07-26-2022 06-30-2022 10-Q
5 05-04-2022 03-31-2022 10-Q
6 02-24-2022 12-31-2021 10-K
7 11-09-2021 09-30-2021 10-Q
8 08-04-2021 06-30-2021 10-Q
9 05-05-2021 03-31-2021 10-Q
10 03-04-2021 12-31-2020 10-K
11 11-03-2020 09-30-2020 10-Q
12 08-06-2020 06-30-2020 10-Q
13 05-07-2020 03-31-2020 10-Q
14 02-27-2020 12-31-2019 10-K
15 11-12-2019 09-30-2019 10-Q
16 08-01-2019 06-30-2019 10-Q
17 05-08-2019 03-31-2019 10-Q
18 02-28-2019 12-31-2018 10-K
19 11-02-2018 09-30-2018 10-Q
20 08-01-2018 06-30-2018 10-Q
21 05-09-2018 03-31-2018 10-Q
22 03-05-2018 12-31-2017 10-K
23 11-08-2017 09-30-2017 10-Q
24 08-02-2017 06-30-2017 10-Q
25 05-03-2017 03-31-2017 10-Q
26 02-28-2017 12-31-2016 10-K
27 11-08-2016 09-30-2016 10-Q
28 08-05-2016 06-30-2016 10-Q
29 05-09-2016 03-31-2016 10-Q
30 02-26-2016 12-31-2015 10-K
31 11-05-2015 09-30-2015 10-Q
32 08-10-2015 06-30-2015 10-Q
33 05-11-2015 03-31-2015 10-Q
34 03-02-2015 12-31-2014 10-K
35 11-12-2014 09-30-2014 10-Q
36 08-06-2014 06-30-2014 10-Q
37 05-13-2014 03-31-2014 10-Q
38 03-11-2014 12-31-2013 10-K
39 11-13-2013 09-30-2013 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

from-ai-to-obesity-drugs---global-pharma-has-700b-for-ma-and-investments-goldman-sachs
From AI to Obesity Drugs - Global Pharma H...
07/07/2023 17:18:25

Goldman Sachs compiled research suggesting the global pharmaceutical sector has approximately $700 billion available for M&...

Core News & Articles
On July 6, At Special Meeting Iveric Bio I...
07/06/2023 17:07:18

- Reuters 

Core News & Articles
10 Health Care Stocks With Whale Alerts In...
05/08/2023 17:35:23

td-cowen-downgrades-iveric-bio-to-market-perform
TD Cowen Downgrades IVERIC bio to Market P...
05/08/2023 15:25:48

TD Cowen analyst Ken Cacciatore downgrades IVERIC bio (NASDAQ:ISEE) from Outperform to Market Perform.

Core News & Articles
Benzinga's Top Ratings Upgrades, Downgrade...
05/04/2023 15:00:45

baird-downgrades-iveric-bio-to-neutral-announces-40-price-target
Baird Downgrades IVERIC bio to Neutral, An...
05/04/2023 10:08:23

Baird analyst Colleen Kusy downgrades IVERIC bio (NASDAQ:ISEE) from Outperform to Neutral and announces $40 price target.

Core News & Articles
Benzinga's Top Ratings Upgrades, Downgrade...
05/03/2023 15:00:39

ubs-downgrades-iveric-bio-to-neutral-raises-price-target-to-40
UBS Downgrades IVERIC bio to Neutral, Rais...
05/03/2023 08:57:36

UBS analyst Eliana Merle downgrades IVERIC bio (NASDAQ:ISEE) from Buy to Neutral and raises the price target from $34 to $40.

Core News & Articles
Benzinga's Top Ratings Upgrades, Downgrade...
05/02/2023 15:00:40

hc-wainwright--co-downgrades-iveric-bio-to-neutral-raises-price-target-to-40
HC Wainwright & Co. Downgrades IVERIC bio ...
05/02/2023 10:13:54

HC Wainwright & Co. analyst Matthew Caufield downgrades IVERIC bio (NASDAQ:ISEE) from Buy to Neutral and raises the pric...

Core News & Articles
Benzinga's Top Ratings Upgrades, Downgrade...
05/01/2023 15:00:42

first-republic-folds-amid-banking-crisis-elon-musk-expects-starship-to-make-orbit-on-next-launch-doj-probes-mastercard-over-anti-competitive-debit-card-practices-todays-top-stories
First Republic Folds Amid Banking Crisis, ...
05/01/2023 13:58:37

Benzinga

12-health-care-stocks-moving-in-mondays-pre-market-session
12 Health Care Stocks Moving In Monday's P...
05/01/2023 13:06:41

wedbush-downgrades-iveric-bio-to-neutral-raises-price-target-to-40
Wedbush Downgrades IVERIC bio to Neutral, ...
05/01/2023 12:46:46

Wedbush analyst David Nierengarten downgrades IVERIC bio (NASDAQ:ISEE) from Outperform to Neutral and raises the price targe...

astellas-pharma-acquires-iveric-bio-for-59b-to-focus-on-blindness--regeneration
Astellas Pharma Acquires Iveric Bio For $5...
05/01/2023 12:00:47

Japanese healthcare company Astellas Pharma Inc (OTC: ALPMY) has agreed to buy Iveric Bio Inc (NASDAQ: ISEE) for $40.00 per sha...

iveric-bio-ascendis-pharma-and-other-big-stocks-moving-higher-in-mondays-pre-market-session
IVERIC bio, Ascendis Pharma And Other Big ...
05/01/2023 11:32:48

U.S. stock futures traded mixed this morning. Here are some big stocks recording gains in today’s pre-market trading session. ...

guggenheim-downgrades-iveric-bio-to-neutral
Guggenheim Downgrades IVERIC bio to Neutral
05/01/2023 11:06:56

Guggenheim analyst Eddie Hickman downgrades IVERIC bio (NASDAQ:ISEE) from Buy to Neutral.

astellas-entered-into-definitive-agreement-to-acquire-iveric-bio-for-40share-in-cash
Astellas Entered Into Definitive Agreement...
04/30/2023 23:15:25

Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") and IVERIC Bio, Inc. (NASDAQ: ISEE, CEO:...

the-latest-analyst-ratings-for-iveric-bio
The Latest Analyst Ratings for IVERIC bio
04/25/2023 18:00:54

morgan-stanley-maintains-overweight-on-iveric-bio-raises-price-target-to-35
Morgan Stanley Maintains Overweight on IVE...
04/25/2023 12:02:11

Morgan Stanley analyst Michael Ulz maintains IVERIC bio (NASDAQ:ISEE) with a Overweight and raises the price target from $30...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION